Molecular analysis of the NF2 tumor-suppressor gene in schwannomatosis

American Journal of Human Genetics

Volumn 61, Issue 6, 1997, Pages 1293-1302

  Jacoby, Lee B ^a   Jones, Deborah ^a   Davis, Kevin ^a   Kronn, David ^b   Short, M Priscilla ^c   Gusella, James ^a   MacCollin, Mia ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b NEW YORK MEDICAL COLLEGE   (United States)

^c UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FAMILY HISTORY; FEMALE; GENE MUTATION; GENETIC LINKAGE; GENETIC PREDISPOSITION; HETEROZYGOSITY LOSS; HUMAN; HUMAN CELL; HUMAN TISSUE; LYMPHOBLAST; MALE; NEURILEMOMA; NEUROFIBROMATOSIS; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

EID: 0031440868     PISSN: 00029297     EISSN: None     Source Type: Journal    
DOI: 10.1086/301633     Document Type: Article

References (37)

1. Anderson M, Gusella J (1984) Use of cyclosporin A in establishing Epstein-Barr virus-transformed human lymphoblastoid cell lines. In Vitro Cell Dev Biol 20:856-858
2. Arpin M, Algrain M, Louvard D (1994) Membrane-actin microfilament connections: an increasing diversity of players related to band 4.1. Curr Opin Cell Biol 6:136-146
3. Berger T, Lapin N, Engel M (1987) Agminated neurilemomas. J Am Acad Dermatol 17:891-894
4. Bijlsma E, Merel P, Bosch DA, Westerveld A, Delattre O, Thomas G, Hulsebos TJM (1994) Analysis of mutations in the SCH gene in schwannomas. Genes Chromosom Cancer 11: 7-14
5. Bourn D, Strachan T (1995) Highly polymorphic dinucleotide repeat at the NF2 gene. Hum Genet 95:712
6. Bouzas E, Parry D, Eldridge R, Kaiser-Kupfer M (1993) Visual impairment in patients with neurofibromatosis 2. Neurology 43:622-623
7. Buenger K, Porter N, Dozier S, Wagner R (1993) Localized multiple neurilemmomas of the lower extremity. Cutis 51: 36-38
8. Evans DGR, Huson SM, Donnai D, Neary W, Blair V, Newton V, Harris R (1992) A clinical study of type 2 neurofibromatosis. Q J Med 304 N Ser 84:603-618
9. Evans DGR, Mason S, Huson SM, Ponder M, Harding AE, Strachan T (1997) Spinal and cutaneous schwannomatosis is a variant form of type 2 neurofibromatosis: a clinical and molecular study. J Neurol Neurosurg Psychiatry 62: 361-366
10. Gonzalez-Agosti C, Xu L, Pinney D, Beauchamp R, Hobbs W, Gusella J, Ramesh V (1996) The merlin tumor suppressor localizes preferentially in membrane ruffles. Oncogene 13: 1239-1247
11. Gutmann D, Aylsworth A, Carley J, Korf B, Marks J, Pyeritz R, Rubenstein A, et al (1997) The diagnostic evaluation and multidisciplinary management of neurofibromatosis 1 and neurofibromatosis 2. JAMA 278:51-57
12. Harkin JC, Reed RT (1969) Tumors of the peripheral nervous system. In: Armed Forces Institute of Pathology atlas of tumor pathology, 2d ser, fasc 3. Universities Associated for Research and Education in Pathology, Bethesda, pp 29-50
13. Honda M, Arai E, Sawada S, Ohta A, Niimura M (1995) Neurofibromatosis 2 and neurilemmomatosis gene are identical. J Invest Dermatol 104:74-77
14. Jacoby LB, MacCollin M, Barone R, Ramesh V, Gusella J (1996) Frequency and distribution of NF2 mutations in schwannomas. Genes Chromosom Cancer 17:45-55
15. Jacoby LB, MacCollin M, Louis D, Mohney T, Rubio MP, Pulaski K, Trofatter J, et al (1994) Exon scanning for mutation of the NF2 gene in schwannomas. Hum Mol Genet 3:413-419
16. Kaiser-Kupfer M, Freidlin V, Datiles M, Edwards P, Sherman J, Parry D, McCain L, et al (1989) The association of posterior capsular lens opacities with bilateral acoustic neuromas in patients with neurofibromatosis type 2. Arch Ophthalmol 107:541-543
17. Lewis R, Nannini L, Cocke W (1981) Multifocal neurilemomas of median and ulnar nerves of the same extremity - case report. J Hand Surg [Am] 6:406-408
18. MacCollin M, Jacoby LB, Jones D, Ojemann R, Feit H, Gusella J (1997a) Somatic mosaicism of the neurofibromatosis 2 tumor suppressor gene. Neurology 48:A429
19. MacCollin M, Kronn D, Davis K, Jones D, Jacoby LB (1997b) Schwannomatosis resulting from somatic mosaicism of the NF2 gene. Ann Neurol 42:513
20. MacCollin M, Ramesh V, Jacoby LB, Louis DN, Rubio M-P, Pulaski K, Trofatter J, et al (1994) Mutational analysis of patients with neurofibromatosis 2. Am J Hum Genet 55: 314-320
21. MacCollin M, Woodfin W, Kronn D, Short M (1996) Schwannomatosis: a clinical and pathologic study. Neurology 46: 1072-1079
22. Marineau C, Baron C, Delattre O, Zucman J, Thomas G, Rouleau G (1993) Dinucleotide repeat polymorphism at the D22S268 locus. Hum Mol Genet 2:336
23. Mautner VF, Tatagiba M, Guthoff R, Samii M, Pulst SM (1993) Neurofibromatosis 2 in the pediatric age group. Neurosurgery 33:92-97
24. Parry DM, Eldridge R, Kaiser-Kupfer MI, Bouzas E, Pikus A, Patronas N (1994) Neurofibromatosis 2 (NF2): clinical characteristics of 63 affected individuals and clinical evidence for heterogeneity. Am J Med Genet 52:450-461
25. Parry DM, MacCollin MM, Kaiser-Kupfer MI, Pulaski K, Nicholson HS, Bolesta M, Eldridge R, et al (1996) Germline mutations in the neurofibromatosis 2 gene: correlations with disease severity and retinal abnormalities. Am J Hum Genet 59:529-539
26. Pulst SM, Riccardi V, Mautner V (1997) Spinal schwannomatosis. Neurology 48:787-788
27. Purcell S, Dixon S (1989) Schwannomatosis - an unusual variant of neurofibromatosis or a distinct clinical entity? Arch Dermatol 125:390-393
28. Ragge N, Baser M, Klein J, Nechiporuk A, Sainz J, Pulst SM, Riccardi V (1995) Ocular abnormalities in neurofibromatosis 2. Am J Ophthalmol 120:634-641
29. Rouleau G, Merel P, Lutchman M, Sanson M, Zucman J, Marineau C, Hoang-Xuan K, et al (1993) Alteration in a new gene encoding a putative membrane-organizing protein causes neuro-fibromatosis type 2. Nature 363:515-521
30. Ruttledge MH, Andermann AA, Phelan CM, Claudio JO, Han F-y, Chretien N, Rangaratnam S, et al (1996) Type of mutation in the neurofibromatosis type 2 gene (NF2) frequently determines severity of disease. Am J Hum Genet 59:331-342
31. Sainz J, Nechiporuk A, Kim J, Simon M, Pulst S (1993) CA-repeat polymorphism at the D22S430 locus adjacent to NF2. Hum Mol Genet 2:2203
32. Sasaki T, Nakajima H (1992) Congenital neurilemmomatosis. J Am Acad Dermatol 26:786-787
33. Shishishiba T, Niimura M, Ohtsuka F, Tsuru N (1984) Multiple cutaneous neurilemmomas as a skin manifestation of neurilemmomatosis. J Am Acad Dermatol 10:744-754
34. Stangl A, Wellenreuther R, Lenartz D, Kraus J, Menon A, Schramm J, Wiestler O, et al (1997) Clonality of multiple meningiomas. J Neurosurg 86:853-858
35. Trofatter J, MacCollin M, Rutter J, Murrell J, Duyao M, Parry D, Eldridge R (1993) A novel moesin-, ezrin-, radixin-like gene is a candidate for the neurofibromatosis 2 tumor suppressor. Cell 72:791-800
36. Weissenbach J, Gyapay G, Dib C, Vignal A, Morissette J, Millasseau P, Vaysseix G, et al (1992) A second generation linkage map of the human genome. Nature 359:794-801
37. Wellenreuther R, Kraus J, Lenartz D, Menon A, Schramm J, Louis D, Ramesh V, et al (1995) Analysis of the neurofibromatosis 2 gene reveals molecular variants of meningioma. Am J Pathol 146:827-832